Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 115K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Yellen-Shaw, A. J. Articles by Eisenlohr, L. C. Search for Related Content PubMed PubMed Citation Articles by Yellen-Shaw, A. J. Articles by Eisenlohr, L. C. Social Bookmarking                            What's this?

Articles

Amy J. Yellen-Shaw^*, Carol E. Laughlin^*, Robert M. Metrione, and Laurence C. Eisenlohr^*

From the ^* Kimmel Cancer Institute and Department of Biochemistry and Molecular Pharmacology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

The transporter associated with antigen presentation (TAP) complex shuttles cytosolic peptides into the exocytic compartment for association with nascent major histocompatibility complex class I molecules. Biochemical studies of murine and human TAP have established that substrate length and COOH-terminal residue identity are strong determinants of transport efficiency. However, the existence of these specificities in the intact cell and their influences on T cell responses have not been demonstrated. We have devised a method for studying TAP- mediated transport in intact cells, using T cell activation as a readout. The approach makes use of a panel of recombinant vaccinia viruses expressing peptides containing the K^d-restricted nonamer influenza nucleoprotein residues 147–155. The COOH terminus of each construct was appended with a dipeptide composed of an internal threonine residue followed by a varying amino acid. Synthetic peptide versions of these 11-mers exhibit vastly different transport capabilities in streptolysin O–permeabilized cells, in accordance with the predicted influence of the COOH-terminal residues. Presentation of the endogenously expressed version of each construct requires TAP-mediated transport and cooexpression with a vac-encoded exocytic COOH-terminal dipeptidase, angiotensin converting enzyme, to allow liberation of the minimal epitope. Recognition by epitope-specific CTLs therefore signifies TAP-mediated transport of a complete 11-mer within the target cell. Under normal assay conditions no influences of the COOH-terminal residue were revealed. However, when T cell recognition was limited, either by blocking CD8 coreceptor interactions or by decreasing the amount of transport substrate synthesized, significant COOH-terminal effects were revealed. Under such conditions, those peptides that transported poorly in biochemical assays were less efficiently presented. Therefore, TAP specificity operates in the intact cell, appears to reflect previously defined rules with regard to the influence of the COOH-terminal residue, and can strongly influence T cell responses.

¹ Abbreviations used in this paper: ACE, angiotensin converting enzyme; IC₅₀, 50% inhibitory concentration; NP, influenza nucleoprotein; TAP, transporter associated with antigen presentation; TE, 147–155TE; TG, 147–155TG; TL, 147–155TL; TM, 147–155TM; TP, 147–155TP; TX, 147–155TX; vac, vaccinia.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Wherry, E. J., Golovina, T. N., Morrison, S. E., Sinnathamby, G., McElhaugh, M. J., Shockey, D. C., Eisenlohr, L. C. (2006). Re-evaluating the Generation of a "Proteasome-Independent" MHC Class I-Restricted CD8 T Cell Epitope. J. Immunol. 176: 2249-2261 [Abstract] [Full Text]  
• Spierings, E., Brickner, A. G., Caldwell, J. A., Zegveld, S., Tatsis, N., Blokland, E., Pool, J., Pierce, R. A., Mollah, S., Shabanowitz, J., Eisenlohr, L. C., Van Veelen, P., Ossendorp, F., Hunt, D. F., Goulmy, E., Engelhard, V. H. (2003). The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood 102: 621-629 [Abstract] [Full Text]  
• Fruci, D., Lauvau, G., Saveanu, L., Amicosante, M., Butler, R. H., Polack, A., Ginhoux, F., Lemonnier, F., Firat, H., van Endert, P. M. (2003). Quantifying Recruitment of Cytosolic Peptides for HLA Class I Presentation: Impact of TAP Transport. J. Immunol. 170: 2977-2984 [Abstract] [Full Text]  
• Wherry, E. J., McElhaugh, M. J., Eisenlohr, L. C. (2002). Generation of CD8+ T Cell Memory in Response to Low, High, and Excessive Levels of Epitope. J. Immunol. 168: 4455-4461 [Abstract] [Full Text]  
• Golovina, T. N., Wherry, E. J., Bullock, T. N. J., Eisenlohr, L. C. (2002). Efficient and Qualitatively Distinct MHC Class I-Restricted Presentation of Antigen Targeted to the Endoplasmic Reticulum. J. Immunol. 168: 2667-2675 [Abstract] [Full Text]  
• Pierce, R. A., Field, E. D., Mutis, T., Golovina, T. N., Kap-Herr, C. V., Wilke., M., Pool, J., Shabanowitz, J., Pettenati, M. J., Eisenlohr, L. C., Hunt, D. F., Goulmy, E., Engelhard, V. H. (2001). The HA-2 Minor Histocompatibility Antigen Is Derived from a Diallelic Gene Encoding a Novel Human Class I Myosin Protein. J. Immunol. 167: 3223-3230 [Abstract] [Full Text]  
• Brickner, A. G., Warren, E. H., Caldwell, J. A., Akatsuka, Y., Golovina, T. N., Zarling, A. L., Shabanowitz, J., Eisenlohr, L. C., Hunt, D. F., Engelhard, V. H., Riddell, S. R. (2001). The Immunogenicity of a New Human Minor Histocompatibility Antigen Results from Differential Antigen Processing. JEM 193: 195-206 [Abstract] [Full Text]  
• Lucchiari-Hartz, M., van Endert, P. M., Lauvau, G., Maier, R., Meyerhans, A., Mann, D., Eichmann, K., Niedermann, G. (2000). Cytotoxic T Lymphocyte Epitopes of HIV-1 Nef: Generation of Multiple Definitive Major Histocompatibility Complex Class I Ligands by Proteasomes. JEM 191: 239-252 [Abstract] [Full Text]  
• Brander, C., Yang, O. O., Jones, N. G., Lee, Y., Goulder, P., Johnson, R. P., Trocha, A., Colbert, D., Hay, C., Buchbinder, S., Bergmann, C. C., Zweerink, H. J., Wolinsky, S., Blattner, W. A., Kalams, S. A., Walker, B. D. (1999). Efficient Processing of the Immunodominant, HLA-A*0201-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitope despite Multiple Variations in the Epitope Flanking Sequences. J. Virol. 73: 10191-10198 [Abstract] [Full Text]  
• Lauvau, G., Kakimi, K., Niedermann, G., Ostankovitch, M., Yotnda, P., Firat, H., Chisari, F. V., van Endert, P. M. (1999). Human Transporters Associated with Antigen Processing (Taps) Select Epitope Precursor Peptides for Processing in the Endoplasmic Reticulum and Presentation to T Cells. JEM 190: 1227-1240 [Abstract] [Full Text]  
• Lauvau, G., Gubler, B., Cohen, H., Daniel, S., Caillat-Zucman, S., van Endert, P. M. (1999). Tapasin Enhances Assembly of Transporters Associated with Antigen Processing-dependent and -independent Peptides with HLA-A2 and HLA-B27 Expressed in Insect Cells. J. Biol. Chem. 274: 31349-31358 [Abstract] [Full Text]  
• Wherry, E. J., Puorro, K. A., Porgador, A., Eisenlohr, L. C. (1999). The Induction of Virus-Specific CTL as a Function of Increasing Epitope Expression: Responses Rise Steadily Until Excessively High Levels of Epitope Are Attained. J. Immunol. 163: 3735-3745 [Abstract] [Full Text]  
• Serwold, T., Shastri, N. (1999). Specific Proteolytic Cleavages Limit the Diversity of the Pool of Peptides Available to MHC Class I Molecules in Living Cells. J. Immunol. 162: 4712-4719 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS